Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS)
CNY 19.97
(1.01%)
CNY 19.97
(1.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -143.21 Million | 43.29 Million | 124.78 Million | 93.61 Million | -24.55 Million | 22.78 Million |
| Net Income | 88.83 Million | 12.81 Million | 21.95 Million | 31.04 Million | 19.42 Million | 31.16 Million |
| Depreciation & Amortization | 45.62 Million | 38.72 Million | 19.62 Million | 11.06 Million | 4.8 Million | 4.33 Million |
| Deferred income taxes | 46.03 Million | -2.63 Million | -18.69 Million | -1.64 Million | -538.9 Thousand | -729 Thousand |
| Stock-based compensation | 322.27 Thousand | 14.93 Million | 35.37 Million | 15.09 Million | 538.9 Thousand | - |
| Change in working capital | -38.03 Million | -21.86 Million | 89.35 Million | 67.53 Million | -38.17 Million | -8.18 Million |
| Other non-cash items | -166.4 Million | 1.32 Million | -22.83 Million | -29.47 Million | -10.6 Million | -4.53 Million |
| Investing Cash Flow | -389.06 Million | -801.7 Million | -30.62 Million | -108.69 Million | -721.47 Million | -13.33 Million |
| Investments in PPE | -229.02 Million | -400.16 Million | -288.46 Million | -336.26 Million | -133.02 Million | -140.74 Million |
| Acquisitions | -40.89 Million | 108.53 Million | 14.98 Thousand | 336.27 Million | 133.04 Million | 5680.00 |
| Investment purchases | -1.27 Billion | -1.04 Billion | -657 Million | -1.53 Billion | -821.05 Million | -305.6 Million |
| Sales/Maturities of investments | 1.15 Billion | 645.63 Million | 914.82 Million | 1.76 Billion | 232.58 Million | 433 Million |
| Other Investing Activities | -41.34 Million | -108.24 Million | 1.38 | -336.26 Million | -133.02 Million | 0.50 |
| Financing Cash Flow | 382.61 Million | 861.28 Million | -63.31 Million | -45.37 Million | 950.2 Million | 17.95 Million |
| Debt repayment | -226.78 Million | -257.67 Million | -90.05 Million | -67.13 Million | -93.5 Million | -76.5 Million |
| Dividends payments | -18.74 Million | -12.16 Million | -4.22 Million | -3.27 Million | -1.48 Million | -549.88 Thousand |
| Common Stock Repurchased | - | -3.8 Million | -155.47 Million | - | - | - |
| Common Stock Issuance | - | 3.8 Million | 155.47 Million | - | - | - |
| Other Financing Activities | 160.13 Million | 1.13 Billion | 30.96 Million | 25.04 Million | 1.04 Billion | 94.99 Million |
| Accounts receivables | -59.11 Million | -42.45 Million | -73.72 Million | 50.22 Million | -37.2 Million | -20.9 Million |
| Accounts payables | 49.75 Million | 42.63 Million | 182.88 Million | 20.37 Million | 2.09 Million | 12.72 Million |
| Inventory | -18.65 Million | -19.4 Million | -1.1 Million | -1.41 Million | -2.52 Million | 722.89 Thousand |
| Other working capital | -10.01 Million | -2.63 Million | -18.69 Million | -1.64 Million | -538.9 Thousand | -8.9 Million |
| Cash at beginning of period | 508.59 Million | 300.15 Million | 271.55 Million | 336.09 Million | 131.27 Million | 102.5 Million |
| Cash at end of period | 375.43 Million | 415.26 Million | 300.15 Million | 271.55 Million | 336.09 Million | 131.27 Million |
| Capital Expenditure | -229.02 Million | -400.16 Million | -288.46 Million | -336.26 Million | -133.02 Million | -140.74 Million |
| Effect of forex changes on cash | 1.08 Million | 12.23 Million | -2.24 Million | -4.08 Million | 645.5 Thousand | 1.36 Million |
| Net cash flow / Change in cash | -133.15 Million | 115.11 Million | 28.59 Million | -64.53 Million | 204.82 Million | 28.76 Million |
| Free Cash Flow | -372.23 Million | -356.87 Million | -163.68 Million | -242.64 Million | -157.57 Million | -117.95 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.07 Million | -22.7 Million | -18.3 Million | -19.24 Million | 88.83 Million | -47.6 Million |
| Depreciation & Amortization | - | 13.87 Million | 13.87 Million | 11.32 Million | 45.62 Million | -21.72 Million |
| Deferred income taxes | - | - | - | - | 46.03 Million | 1.77 Million |
| Stock-based compensation | - | - | - | 322.27 Thousand | 322.27 Thousand | -7.77 Million |
| Change in working capital | - | 45.79 Million | - | -87.78 Million | -38.03 Million | 23.82 Million |
| Other non-cash items | 71.16 Million | 17.85 Million | 56.93 Million | -33.64 Million | -166.4 Million | 60.88 Million |
| Investing Cash Flow | -132.33 Million | -174.31 Million | 22.27 Million | 5.97 Million | -389.06 Million | -168.44 Million |
| Investments in PPE | -122.79 Million | -42.73 Million | -45.81 Million | -5.64 Million | -229.02 Million | -61.4 Million |
| Acquisitions | 1106.19 | 792.03 | - | -40.89 Million | -40.89 Million | 41.34 Million |
| Investment purchases | -333.47 Million | -445.84 Million | -395.81 Million | -321.93 Million | -1.27 Billion | -359.49 Million |
| Sales/Maturities of investments | 323.93 Million | 314.27 Million | 463.9 Million | 374.45 Million | 1.15 Billion | 252.42 Million |
| Other Investing Activities | 1106.19 | -130.42 Million | 71.28 Million | -1.00 | -41.34 Million | -41.31 Million |
| Financing Cash Flow | 65.12 Million | 33.6 Million | 33.41 Million | 43.56 Million | 382.61 Million | 27.23 Million |
| Debt repayment | -72.4 Million | -40.53 Million | -55.63 Million | -49.96 Million | -226.78 Million | -31.48 Million |
| Dividends payments | -6.22 Million | -6.02 Million | -6.14 Million | -5.45 Million | -18.74 Million | -5.24 Million |
| Common Stock Repurchased | - | -15 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.05 Million | -6.93 Million | -22.22 Million | -2.09 Million | 160.13 Million | 63.96 Million |
| Accounts receivables | - | 49.47 Million | - | -59.11 Million | -59.11 Million | 26.96 Million |
| Accounts payables | - | - | - | - | 49.75 Million | - |
| Inventory | - | -2.7 Million | - | -18.65 Million | -18.65 Million | -3.14 Million |
| Other working capital | - | -975.84 Thousand | - | -10.01 Million | -10.01 Million | 9.14 Million |
| Cash at beginning of period | 201.94 Million | 467.87 Million | 375.43 Million | 361.59 Million | 508.59 Million | 392.91 Million |
| Cash at end of period | 193.07 Million | 328.18 Million | 467.87 Million | 375.43 Million | 375.43 Million | 259.62 Million |
| Capital Expenditure | -122.79 Million | -42.73 Million | -45.81 Million | -5.64 Million | -229.02 Million | -61.4 Million |
| Effect of forex changes on cash | -669.59 Thousand | 212.87 Thousand | 163.68 Thousand | -914.67 Thousand | 1.08 Million | -1.45 Million |
| Net cash flow / Change in cash | -8.86 Million | -139.68 Million | 92.43 Million | 13.84 Million | -133.15 Million | -133.29 Million |
| Free Cash Flow | -61.7 Million | -61.47 Million | -7.18 Million | -47.2 Million | -372.23 Million | -52.04 Million |
8066
097230
CMNP
MRSKF
ALPHAGEO
TRU